Amarin
AMRNAmarin Corporation is a biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their le …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Amarin
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/22/2024 | Buy | Holt, Patrick | President and CEO | $1.1 | $15,724 |
| 12/12/2023 | Sell | Ketchum, Steven B. | Chief Scientific Officer | $0.8 | $26,963 |
| 8/16/2023 | Buy | Holt, Patrick | President and CEO | $1.0 | $312,315 |
| 6/13/2022 | Buy | Wold, Olsen Per | Director | $1.7 | $92,730 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)